Delphinidin is an anthocyanin pigment found in a variety of blue, red and purple fruits such as blueberries, black currants, and cranberries. Delphinidin typically is found together with other anthocyanins. For example, blueberries contain the anthocyanins cyanidin, malvidin, peonidin, and petunidin, in addition to delphinidin. All blue/red/purple dark-fleshed fruits have been found to be associated with reduced breast cancer risk and recurrence. It is likely that the micronutrients in such fruits act synergistically to prevent breast cancer growth and proliferation. However, they also act individually when tested in the laboratory. Now a new study has reported that delphinidin inhibits carcinogen-induced transformation of normal cells into breast cancer cells and also inhibits tumor growth in a mouse model of triple negative (ER-/PR-/HER2-) breast cancer.
Food sources of delphinidin
The most abundant sources of delphinidin are given below:
Latest research finds delphinidin inhibits breast cancer development
The study referenced at the beginning of this new story was designed to investigate the mechanism of action by which delphinidin-3-glucoside reduces breast carcinogenesis and growth, including the role of the Akt/HOTAIR signaling pathway. Activation of the Akt gene is frequently observed in human cancer cells. In particular, long non-coding RNA (lncRNA) HOX transcript antisense RNA (HOTAIR) plays an important part in cancer progression. This is regulated by the interferon regulatory factor-1 (IRF1) and up-streaming Akt activation. Therefore, down-regulation of Akt/HOTAIR signaling is one possible strategy for breast cancer prevention.
To conduct the study, the authors first treated non-cancerous MCF-10A human breast cells either with two carcinogens or with the carcinogens plus delphinidin for 30 days. The cells were then evaluated for cancer-associated properties using a variety of tests. Exposure to the carcinogens was found to induce malignant transformation in breast cells. This transformation was effectively suppressed in cells co-treated with delphinidin through inactivation of the Akt/HOTAIR signaling pathway.
In a second experiment, the authors implanted bioluminescent MDA-MB-231-Luc-GFP triple negative breast cancer cells in mice to generate tumors in them. Delphinidin was found to inhibit the growth of these xenografted breast tumors, again by decreasing HOTAIR. The authors conclude that the findings suggest that delphinidin is effective in inhibiting breast carcinogenesis, in part through down-regulation of HOTAIR.